When people hear dosage, they often think of medication. But dosage is a broader clinical concept. It is the structure that makes an intervention legible to clinicians, payers, and regulators. For VR therapy, dosage is the answer to simple questions that are still surprisingly inconsistent across studies and pilots. The post From Pilots to Protocols:…
Shifting healthcare dollars into individual-controlled accounts would mark an inflection point. But even without full policy execution, consumer wallet economics are expanding. The race is now on to build the infrastructure layer between individual spending authority and care delivery. The post When Health Dollars Move to Individuals, Infrastructure Will Decide Who Wins appeared first on…
Anterior raised $40 million to expand its AI platform that automates administrative clinical work for health plans. The system can approve care in minutes rather than weeks, aiming to reduce costs and ease the workload for clinicians and payer staff. The post Anterior Snags $40M to Speed Care Approvals with AI appeared first on MedCity…
PTC Therapeutics said it cannot resolve differences it has with the FDA in interpreting clinical trial data for Translarna, a drug it developed for Duchenne muscular dystrophy. The rare disease drug developer’s decision to withdraw Translarna’s FDA submission comes nearly a year after a negative European regulatory decision for the drug. The post PTC Therapeutics…
VBC models deliver significant benefits for CKD management by coordinating medical, behavioral, and social support through multidisciplinary teams. This approach enables providers to personalize care, address barriers to access, and use data-driven strategies to identify and prioritize high-risk patients. The post Closing the CKD Care Gap with Value-Based Care Models appeared first on MedCity News.
Giving healthcare teams powerful AI tools without training undermines their ability to use potentially system-changing tools safely and effectively. The post AI Can’t Improve Healthcare if Clinicians and Staff Aren’t Trained to Use, Orchestrate It appeared first on MedCity News.
Mayo Clinic has about 100 petabytes of structured and unstructured EHR data, and about 28 petabytes have been de-identified, but in the Mayo Clinic way. Now that data capability is being combined with institutional expertise to provide a compelling case for pharma companies looking to leverage data, AI and provider expertise in drug development The…
Infigratinib achieved statistically significant improvement in growth rate and body composition in a Phase 3 clinical trial that tested the BridgeBio Pharma drug in achondroplasia, the most common form of dwarfism. Regulatory submissions are planned for later this year. The post BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA…
Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving outcomes as competition intensifies across behavioral health and virtual care. The post Talkiatry Rakes In $210M…
The AI revolution doesn’t mean erasing the value of humans. It means giving nurses more time to do what they signed up to do — deliver care directly to patients. The post Empathetic AI Nurses Can Vastly Improve Nurses’ Work and Patient Care appeared first on MedCity News.